Telehealth platform KonsultaMD said it signed strategic partnership with Southstar Drug and Singapore Diagnostics to expand the scope and widen the reach of pharmacy and laboratory services across the nation.
“Through the digital transformation of healthcare, people across the Philippines can actively participate in ensuring the consistent availability of vital medications via online platforms, even in remote regions where physical pharmacies are limited,” said Mariel Crisostomo, general manager of Southstar Drug.
KonsultaMD said it will offer a more complete healthcare journey in collaboration with Singapore Diagnostics (SGD), a significant player in medical diagnostics in Southeast Asia catering to 100,000 patients a month. Known for processing laboratory requirements for over 600 healthcare institutions, SGD’s expertise will enhance KonsultaMD’s ability to provide at-home and in-clinic healthcare services.
“We at Singapore Diagnostics want to bring world-class healthcare to as many Filipinos as possible. With this intent, our partnership with KonsultaMD makes a lot of sense. We will be stronger together and help each other achieve our respective visions,” said Ritche Evidente, president and chief executive of Singapore Diagnostics.
Cholo Tagaysay, chief of KonsultaMD, said the company aimed to make quality healthcare universal for Filipinos.
“By strategically partnering with different health institutions and pharmacies, we can empower our patients and make their healthcare journey hassle-free and convenient,” he said.
